Background and study aims: Being a caregiver for someone with cancer can be very difficult emotionally. For many the patient is a family member or friend, and so this can cause the caregiver a great deal of psychological distress. There are currently very few studies looking into the effectiveness of psychological treatments for distressed caregivers of cancer patients. This study is looking at tailored group therapy program for carers of cancer givers. The aim of this study is to find out whether this program can help to lower levels of distress in cancer caregivers and help them to better cope with caring for someone with the illness.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Distress
measured using the Questionnaire on Stress in Caregivers of Cancer Patients Revised version (QSC-R10C)
Time frame: change from baseline distress at 1 week post treatment
Depression
measured using the Patient Health Questionnaire-9 (PHQ-9)
Time frame: change from baseline depression at 1 week post treatment and at 6 months post treatment
Anxiety
measured using the Generalized Anxiety Disorder-7 (GAD-7)
Time frame: change from baseline anxiety at 1 week post treatment and at 6 months post treatment
General distress
measured using the Distress Thermometer (NCCN DT)
Time frame: change from baseline general distress at 1 week post treatment and at 6 months post treatment
Unmet needs
measured using the Supportive Care Needs Survey - Partners \& Caregivers (SCNS-P\&C-G)
Time frame: change from baseline unmet needs at 1 week post treatment and at 6 months post treatment
Self-efficacy in coping with the cancer disease
measured using the adapted General Perceived Self-Efficacy Scale
Time frame: change from baseline self-efficacy at 1 week post treatment and at 6 months post treatment
Utilisation of primary healthcare
measured via the number of visits with the individual primary care physician
Time frame: change from baseline to 1 week post treatment and 6 months post treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Positive bonding with the group
measured via the Positive Bonding Scale of the Group Questionnaire (GQ-D)
Time frame: change from baseline bonding at 1 week post treatment and 6 months post treatment